Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infinity Bio offers advanced antibody reactome profiling services using its proprietary MIPSA™ technology. The company supports applications in biomarker discovery, translational research, vaccine development, immuno-oncology target identification, and patient stratification. Its services are used by academic institutions, biopharma companies, and government agencies to gain high-resolution insights into immune responses across diverse disease areas. Infinity Bio recently expanded its capabilities through the acquisition of Serimmune's assets and continues to launch new service offerings such as EnviroSIGHT™, HuSIGHT™, VirSIGHT™, AllerSIGHT™, and MuSIGHT™.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infinity Bio.